Healthcare • Medical Instruments & Supplies
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if RGEN is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
51 top institutions tracked
Last 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 8 days ago
Red flags: 2
481 filers reported a long position in RGEN for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $734.7M | 5.4M | -10.1% |
| FMR LLC | $453.9M | 3.3M | +15.2% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | $380.8M | 2.8M | +0.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | $329M | 2.4M | +0.6% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $315.6M | 2.3M | +0.3% |
| MAVERICK CAPITAL LTD | $270.8M | 2M | +30.7% |
| STATE STREET CORP | $245.7M | 1.8M | +1.3% |
| PRICE T ROWE ASSOCIATES INC /MD/ | $239.1M | 1.8M | -64.1% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $220.6M | 1.6M | +15.7% |
| WASATCH ADVISORS LP | $217M | 1.6M | +27.9% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.